Clinical significance of atrial fibrillation after myocardial infarction

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 9, 2011, Pages 1111-1113

  Aronson, Doron ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

acute myocardial infarction; atrial fibrillation; heart failure; stroke

Indexed keywords

ACUTE CORONARY SYNDROME; ARTICLE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; MORTALITY; RISK FACTOR; STROKE;

EID: 80053120945     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.11.101     Document Type: Article

References (12)

1. Jabre P, Jouven X, Adnet F et al. Atrial fibrillation and death after myocardial infarction: a community study. Circulation 123(19), 2094-2100 (2011).
2. Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur. Heart J. 30(9), 1038-1045 (2009).
3. Siu CW, Jim MH, Ho HH et al. Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke. Chest 132(1), 44-49 (2007).
4. Bahouth F, Mutlak D, Furman M et al. Relationship of functional mitral regurgitation to new-onset atrial fibrillation in acute myocardial infarction. Heart 96(9), 683-688 (2010).
5. Lopes RD, Elliott LE, White HD et al. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur. Heart J. 30(16), 2019-2028 (2009).
6. Aronson D, Mutlak D, Bahouth F et al. Restrictive left ventricular filling pattern and risk of new-onset atrial fibrillation after acute myocardial infarction. Am. J. Cardiol. 107(12), 1738-1743 (2011).
7. Aronson D, Boulos M, Suleiman A et al. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. Am. J. Cardiol. 100(5), 753-757 (2007). (Pubitemid 47268263)
8. Alasady M, Abhayaratna WP, Leong DP et al. Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction. Heart Rhythm 8(7), 955-960 (2011).
9. Bode F, Sachs F, Franz MR. Tarantula peptide inhibits atrial fibrillation. Nature 409(6816), 35-36 (2001). (Pubitemid 32098613)
10. Jons C, Jacobsen UG, Joergensen RM et al. The incidence and prognostic significance of new-onset atrial fibrillation in patients with acute myocardial infarction and left ventricular systolic dysfunction: a CARISMA substudy. Heart Rhythm 8(3), 342-348 (2011).
11. Nilsson KR Jr, Al-Khatib SM, Zhou Y et al. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) trial. Heart 96(11), 838-842 (2010).
12. Lip GY, Huber K, Andreotti F et al. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoingcoronary stenting: executive summary - a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 31(11), 1311-1318 (2010).